Top View
- Stembook 2018.Pdf
- Interactions of Retigabine with Topiramate in the Mouse Tonic-Clonic Seizure Model and Chimney Test – an Isobolographic Analysis
- Meclofenamic Acid and Diclofenac, Novel Templates of KCNQ2/Q3 Potassium Channel Openers, Depress Cortical Neuron Activity and Exhibit Anticonvulsant Properties
- Treatment of Women with Epilepsy
- Analysis of Antiepileptic Drugs in Plasma for Clinical Research Stephen Balloch, Lisa Calton, and Gareth Hammond Waters Corporation, Wilmslow, UK
- Novel Antiepileptic Drugs
- Ezogabine (Potiga) National Drug Monograph November 2014 VA Pharmacy Benefits Management Services, Medical Advisory Panel, and VISN Pharmacist Executives
- Retigabine (Trobalt) for the Adjunctive Treatment of Partial Onset Seizures
- 022345Orig1s000
- Brand Generic Guide
- Medicinal Product No Longer Authorised
- Retigabine Induced Oral Mucosal Dyspigmentation of the Hard Palate Nicholas G
- Diclofenac Influence on the Anticonvulsant Effect of Retigabine
- The Role of Gilbert's Syndrome and Frequent NAT2 Slow Acetylation
- Pharmacology and Toxicology
- Extract from the Clinical Evaluation Report for Retigabine
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- The Anticonvulsant Retigabine Is a Subtype Selective Modulator of GABAA Receptors
- Retigabine (Adults) ▼
- Antiepileptic Treatment Selector
- Poster Session Iiiwednesday, December 9, 2015
- The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker
- Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Molecular Mechanisms of Modulation of KV7 Channels by Polyunsaturated Fatty Acids and Their Analogues
- CAS Number Index
- Novel KV7 Ion Channel Openers for the Treatment of Epilepsy and Implications for Detrusor Tissue Contraction T
- Overview ASDERA – Market Need / Opportunity
- Product Information for Retigabine
- Étude Des Mécanismes De Régulation Synaptique De La Balance
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Australian Public Assessment Report for Retigabine
- Interactions with PBC Agents
- Ethanol Withdrawal Drives Anxiety-Related Behaviors by Reducing M-Type Potassium Channel Activity in the Lateral Habenula
- CENTER HEARTBEAT from Molecule to Bedside to Study & Treat Rhythm Disorders of the Heart
- Studies Describing Baseline Dialysate Concentrations for Asparagine
- COVID Therapy Interaction
- Beneficial Effect of Retigabine on Memory in Rats Receiving Ethanol
- Interactions Between Antiepileptics and Second-Generation Antipsychotics
- Drug Interactions Involving the New Second- and Third- Generation Antiepileptic Drugs
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
- Therapeutic Drug Monitoring of Antiepileptic Drugs Table
- Retigabine Stimulates Human KCNQ2/Q3 Channels in the Presence of Bupivacaine Mark A
- 022345Orig1s000
- Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
- Approccio Clinico Al Paziente Con Convulsioni
- Annexes to the European Medicines Agency's 2012 Annual Report
- Recent Treatment Advances and Novel Therapeutic Approaches in Epilepsy Enrique Serrano and Andres M
- Dosing Strategies for Antiepileptic Drugs: from a Standard Dose for All to Individualised Treatment by Implementation of Therapeutic Drug Monitoring
- Atomic Basis for Therapeutic Activation of Neuronal Potassium Channels
- Antiepileptic Drugs and Migraine
- Characterization in Rodent Seizure and Epilepsy Models